BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 33812986)

  • 1. The hallmarks of ovarian cancer stem cells and niches: Exploring their harmonious interplay in therapy resistance.
    Motohara T; Yoshida GJ; Katabuchi H
    Semin Cancer Biol; 2021 Dec; 77():182-193. PubMed ID: 33812986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the tumour microenvironment in platinum-resistant ovarian cancer.
    Cummings M; Freer C; Orsi NM
    Semin Cancer Biol; 2021 Dec; 77():3-28. PubMed ID: 33607246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Microenvironment in Resistance to Therapy in AML.
    Tabe Y; Konopleva M
    Curr Hematol Malig Rep; 2015 Jun; 10(2):96-103. PubMed ID: 25921386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An emerging role for cellular crosstalk in the cancer stem cell niche.
    Oshimori N; Guo Y; Taniguchi S
    J Pathol; 2021 Jul; 254(4):384-394. PubMed ID: 33634866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The correlation of hematopoietic stem cells with cancer stem cells through the regulation of stromal cells in tumor microenvironment.
    Lin S; Fu S
    Med Hypotheses; 2013 Apr; 80(4):494-7. PubMed ID: 23317540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of early events influencing the settlement of cancer cells in metastatic niches].
    Marceaux C; Asselin-Labat ML
    Med Sci (Paris); 2020 Feb; 36(2):109-112. PubMed ID: 32129744
    [No Abstract]   [Full Text] [Related]  

  • 7. [The stem cell niche in glioblastoma: from fundamental aspects to targeted therapies].
    Turpin A; Sharif A; Stoven L; Blond S; Maurage CA; Le Rhun É
    Bull Cancer; 2015 Jan; 102(1):24-33. PubMed ID: 25609493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal niches of bone marrow in cancer.
    Abarrategi A; Marińas-Pardo L; Mirones I; Rincón E; García-Castro J
    Clin Transl Oncol; 2011 Sep; 13(9):611-6. PubMed ID: 21865132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cancer stem cell niche--there goes the neighborhood?
    Cabarcas SM; Mathews LA; Farrar WL
    Int J Cancer; 2011 Nov; 129(10):2315-27. PubMed ID: 21792897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipose-derived stem cells in ovarian cancer progression, metastasis, and chemoresistance.
    Zhang W; Torres-Rojas C; Yue J; Zhu BM
    Exp Biol Med (Maywood); 2021 Aug; 246(16):1810-1815. PubMed ID: 34229470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer Microenvironment: What Can We Learn from the Stem Cell Niche.
    Lacina L; Plzak J; Kodet O; Szabo P; Chovanec M; Dvorankova B; Smetana K
    Int J Mol Sci; 2015 Oct; 16(10):24094-110. PubMed ID: 26473842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the microenvironment in ovarian cancer stem cell maintenance.
    Pasquier J; Rafii A
    Biomed Res Int; 2013; 2013():630782. PubMed ID: 23484135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hypoxic peri-arteriolar glioma stem cell niche, an integrated concept of five types of niches in human glioblastoma.
    Aderetti DA; Hira VVV; Molenaar RJ; van Noorden CJF
    Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):346-354. PubMed ID: 29684521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?
    Plaks V; Kong N; Werb Z
    Cell Stem Cell; 2015 Mar; 16(3):225-38. PubMed ID: 25748930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the clinical value of tumor microenvironment in platinum-resistant ovarian cancer.
    Ghoneum A; Almousa S; Warren B; Abdulfattah AY; Shu J; Abouelfadl H; Gonzalez D; Livingston C; Said N
    Semin Cancer Biol; 2021 Dec; 77():83-98. PubMed ID: 33476723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer Stem Cells in Ovarian Cancer-A Source of Tumor Success and a Challenging Target for Novel Therapies.
    Wilczyński JR; Wilczyński M; Paradowska E
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of tumor microenvironment in cancer stem cell chemoresistance and recurrence.
    Das M; Law S
    Int J Biochem Cell Biol; 2018 Oct; 103():115-124. PubMed ID: 30153480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Cancer Stem Cells to Overcome Therapy Resistance in Ovarian Cancer.
    Muñoz-Galván S; Carnero A
    Cells; 2020 Jun; 9(6):. PubMed ID: 32512891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment.
    Motohara T; Masuda K; Morotti M; Zheng Y; El-Sahhar S; Chong KY; Wietek N; Alsaadi A; Carrami EM; Hu Z; Artibani M; Gonzalez LS; Katabuchi H; Saya H; Ahmed AA
    Oncogene; 2019 Apr; 38(16):2885-2898. PubMed ID: 30568223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic reprogramming: the emerging concept and associated therapeutic strategies.
    Yoshida GJ
    J Exp Clin Cancer Res; 2015 Oct; 34():111. PubMed ID: 26445347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.